Implant company RTI Surgical has signed an agreement with Oxford Performance Materials (OPM) to use their OsteoFab technology platform for spinal applications in the U.S.
OPM’s OsteoFab technology allows for 3D printing implantable medical devices using their proprietary OXPEKK material, a biocompatible polymer. These implants, 3D printed on EOSINT P800 laser sintering systems, are designed enable bone on-growth and were cleared by the FDA in July last year.
Under the agreement, OPM will manufacture RTI’s spinal implant designs using OsteoFab technology, and RTI will oversee finishing steps, packaging, marketing and distribution of finished products.
Brian K. Hutchison, President and CEO of RTI Surgical said: “We are thrilled to announce this agreement with Oxford Performance Materials. OsteoFab is an incredibly exciting technology that creates new opportunities for innovation in the spinal implant market. We look forward to working with OPM to offer our customers and their patients a new alternative for spinal implants.”
“We see RTI Surgical as a growth company in the spinal implant space,” said Scott DeFelice, chairman and CEO of OPM. “RTI is a leading developer of medical implants with a long history of putting sound science behind their products. From the outset, RTI has worked closely with us and we look forward to a lengthy and productive relationship that leverages the unique benefits of OsteoFab technology to improve patient care.”